Biberi-Moroeanu S, Tiţeica-Boldeanu M, Munţiu A, Petrenco M, Suter C
Virologie. 1986 Jan-Mar;37(1):3-8.
From 1979 to 1985 a serological survey was carried out to evaluate the opportunity to start measles vaccination at the age of 9 months. The following aspects were investigated: the persistence of maternal measles antibodies in 188 infants aged 1-8 months: such antibodies could not be detected over 7 months of age; the antibody response to measles vaccination in 181 infants vaccinated at the age of 9-11 months versus 291 children vaccinated when aged more than 12 months: no significant differences were found between the two groups; the age-specific persistence of vaccine-induced hemagglutination-inhibiting antibodies during the 1-4 years following vaccination: no significant difference was found in terms of the children's age upon vaccination. The results lend support to the recommendation to consider 9 months as a satisfactory age to initiate measles immunization in Romania.
1979年至1985年期间,开展了一项血清学调查,以评估在9个月龄开始接种麻疹疫苗的时机。调查了以下几个方面:188名1至8个月龄婴儿体内母体麻疹抗体的持续时间:7个月龄以上的婴儿无法检测到此类抗体;181名9至11个月龄接种麻疹疫苗的婴儿与291名12个月龄以上接种疫苗的儿童的抗体反应:两组之间未发现显著差异;接种疫苗后1至4年内疫苗诱导的血凝抑制抗体的年龄特异性持续时间:接种疫苗时儿童的年龄方面未发现显著差异。这些结果支持了在罗马尼亚将9个月龄视为开始麻疹免疫接种的适宜年龄这一建议。